Physician profile
Radhakrishnan Ramaraj
NPI 1205009891
$3,943.54
in general payments reported to CMS, 2019-2025
36 companies · $800 in 2025
The $800 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $703 · 2020: $317 · 2021: $576 · 2022: $558 · 2023: $575 · 2024: $414 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $427.23 | 2019-2025 | Bodyguardian, Eluvia, Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $399.81 | 2019-2024 | Xarelto |
| Philips North America LLC | $393.79 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $392.21 | 2019-2024 | |
| Cms Imaging, INC. | $348.44 | 2025 | |
| Abbott Laboratories | $292.22 | 2019-2025 | Jot Dx |
| Siemens Medical Solutions USA, INC. | $187.14 | 2024-2025 | Symbia_evo, Cios Alpha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $180.30 | 2019-2025 | Lifevest |
| Ziehm-Orthoscan, INC. | $142.65 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $95.40 | 2021-2025 | Camzyos |
| Novo Nordisk INC | $83.94 | 2021-2023 | Ozempic |
| Irhythm Technologies, INC. | $79.62 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Bard Peripheral Vascular, INC. | $72.57 | 2024-2025 | Venovo, Venclose Maven Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.54 | 2019-2022 | |
| Venclose INC. | $72.20 | 2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $69.59 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $60.39 | 2022 | |
| Baxter Healthcare | $54.13 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Medtronic Vascular, INC. | $50.71 | 2020 | |
| Edwards Lifesciences Corporation | $49.54 | 2022-2023 | Mitris Resilia Mitral Valve |
| Merck Sharp & Dohme LLC | $45.87 | 2021 | |
| Esperion Therapeutics, INC. | $42.00 | 2020-2021 | |
| Amarin Pharma, INC. | $40.82 | 2020 | |
| Medtronic, INC. | $40.68 | 2021 | |
| Galderma Laboratories, L.P. | $34.25 | 2021 | |
| Celgene Corporation | $33.32 | 2023 | Camzyos |
| Amgen INC. | $29.49 | 2019-2021 | |
| Heartflow, INC. | $26.78 | 2025 | |
| Bridgebio Pharma, INC. | $23.90 | 2025 | Attruby |
| Medicomp INC | $21.50 | 2023 | Telepatch Cardiac Monitor |
| Becton, Dickinson and Company | $15.79 | 2023 | Venclose Maven Catheter |
| Biocompatibles, INC. | $15.57 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.49 | 2022 | |
| Cashflow Solutions, LLC | $12.72 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Intact Vascular, INC. | $11.01 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $10.93 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radhakrishnan Ramaraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.